Skip to main content

Haptic Feedback Surgical Environment Market is expected to grow at a CAGR of 14.6%,

 The global haptic feedback surgical environment market was valued at $22.8 million in 2020 and is anticipated to reach $101.4 million by 2031, growing at a CAGR of 14.6%, during the forecast period 2021-2031. 



Increasing implementation of haptic technologies into consumer devices such as mobile phones, wearables devices such as smartwatches, and their increasing adoption in the automotive industry are the prime reasons that are bolstering the overall growth of the global haptic technologies market.

Haptic technology is adopted in various end-user industry verticals, including automotive, consumer goods, transportation, and medical, among others. The adoption of haptic technology is relevantly new in the healthcare domain and slowly gaining market traction with the advancement in technologies. The first use of haptic technology in the healthcare domain involves the use of medical simulators for doctors, and now, different types of simulators are available in the market ranging from training simulators, surgical instrument simulators, robotic surgery simulators to VR simulators.

The overall landscape of the healthcare industry is evolving at a very rapid pace by adopting advanced technologies, including virtual reality, augmented reality, and telepresence surgeries. Haptic technology is aimed to provide and create a realistic sense of feel in a virtual environment; however, the adoption of these technologies are still at a nascent stage, and with time, it can be said that this technology will be widely adopted in the healthcare domain as it enhances the performance of the clinical procedures

 As the technology evolves for medical solutions, the opportunities for haptic technology will also grow due to the increasing demand for implementing haptics in surgical instruments. The use of medical simulation tools has been proposed as the next major step in the evolution of health science education.

 Promising technological advancements have been made by designing and developing haptic devices with low inertia, adjustable impedance range, high sensing resolution to track task simulations. The large and bulky haptic devices were evolved into wearable gloves and contactless haptic devices, which are still in the research phase.

The global haptic feedback surgical environment market consists of large-scale as well as small-scale manufacturers and vendors. Presently, the manufacturers in the market have ample number of opportunities to expand their offerings and to establish a strong foothold in the market. 

There are many companies in the global haptic feedback surgical environment market some which are 3D Systems Corporation, Force Dimension, Forsslund Systems AB, Haption S.A., Orb Surgical Ltd., and Moog, Inc.

Request a Sample - https://bisresearch.com/requestsample?id=1115&type=download


Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more

PD-1/PDL-1 Inhibitor Market Growth Prospects, Emerging Trends and Forecast to 2032

  PD-1/PDL-1 inhibitors are immune-therapeutic agents used in the treatment of various cancer indications, mostly in the advanced stages. PD-1/PDL-1 inhibitors are monoclonal antibodies majorly of IgG1 and IgG4 types to be administered to patients via injection The current market already has seven approved products in the U.S. and a large number of research activities are currently undergoing in this segment generating interest of commercial as well as academic research institutions. In the current period of precision medicine and providing targeted treatment, identification of target patient has become very important as well as complicated. With the emergence of diagnostic test identifying predictive biomarkers, the selection and administration of targeted treatment has become comparativlely conveninent and efficient. PD-1/PDL-1 inhibitors market   are majorly indicated for the treatment of advanced cases of different cancer indications. The PD-1/PDL-1 inibitor treatment has ...
Post a Comment
Read more